Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. ABCB
10. WKC

Go back to Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.13 -0.37 (3.89%)
Previous Close $9.50    52 Week High $9.23 
Open $9.68    52 Week Low $1.16 
Day High $9.99    P/E N/A 
Day Low $9.08    EPS $-0.30 
Volume 9,458,295